Sentences with phrase «translational research approach»

Our translational research approach means that every day you'll be able to work alongside clinicians, collaborating in the laboratory and at the bedside, to develop breakthrough therapies that will help patients feel better, sooner.

Dr. Sonntag studies this concept on the molecular and cellular level using a translational research approach that integrates the analysis of human material, such as postmortem brains, primary cell systems, and neural cell populations generated from patients» - or healthy individuals» - derived induced pluripotent stem cells (iPSC), or induced neurons (iNs), in combination with molecular, biochemistry, and lentivirus - mediated gene - engineering technologies.

Not exact matches

Such an interdisciplinary approach requires more than just taking ideas from a foreign field back to your home turf, Sarah Gehlert, director of the Center for Interdisciplinary Health Disparities Research (CIHDR) at the University of Chicago, said in February during a panel discussion on translational research at the AAAS annual meeting in Research (CIHDR) at the University of Chicago, said in February during a panel discussion on translational research at the AAAS annual meeting in research at the AAAS annual meeting in Chicago.

D. approach isn't very common, it's increasingly recognized as excellent preparation for a career in translational research.

His primary clinical and research focus is dementia, with specific areas of interest including biomarkers to assist in the diagnosis and understanding of disease mechanisms for Alzheimer's and Parkinson's disease, and translational research using novel therapeutic approaches.

By employing a translational approach and utilizing cutting - edge molecular tools, his research group has made outstanding contributions to our understanding of the mechanisms behind the development of chronic lymphocytic leukemia (CLL), the most common adult leukemia.

«The unique aspect of this approach is the ability to improve symptoms and decrease joint damage while potentially avoiding any negative effects on normal immune responses and susceptibility to infections,» adds co-author Gary S. Firestein, M.D., dean and associate vice chancellor of Translational Medicine and director of the Clinical and Translational Research Institute at UCSD.

Firestein, who is also director of the Clinical and Translational Research Institute at UC San Diego, said the work «opens up the potential for precision medicine approaches that allow us to target all of the joints, not just a subset.

«RNAi therapies are a unique approach to cancer treatment as they have the potential to «turn off» the genes» coding for proteins involved in cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director of the Virginia G. Piper Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of specific proteins involved in tumor growth.»

The designation recognizes the Center's collaborative environment and expertise in harnessing translational research to bridge scientific discovery to clinical delivery, with the ultimate goal of successfully introducing novel diagnostic, therapeutic and preventive approaches to cancer.

We are known for our cutting edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes, even early and subtle changes, that help our clients quantify the efficacy of their treatments before they move into the clinic.

Research utilizing basic, translational, or clinical approaches is appropriate.

The Center for Translational Genomics and Bioinformatics strongly supports as well as initiates novel, interdisciplinary research that will project IRCCS Ospedale San Raffaele towards tackling disease through - omics driven translationaTranslational Genomics and Bioinformatics strongly supports as well as initiates novel, interdisciplinary research that will project IRCCS Ospedale San Raffaele towards tackling disease through - omics driven translationaltranslational approaches.

Correlation of clinical and biological information on the individual level is a long - standing goal for a translational approach to oncological research.

Along with more traditional training experiences, we propose new approaches modeled on interdisciplinary interactions that focus on translational and clinical research training.

Our group is specifically working on improvement of islet isolation and transplantation protocols in clinical practice and the development of novel therapeutic options in the field of beta cell replacement with a clear translational «bench to bedside» approach by linking experimental research with preclinical and clinical work:

She Chairs the Scientific Advisory Board (SAB) of NASA's Translational Research Institute (TRI) at Baylor College of Medicine in Houston, charged with researching and developing innovative approaches to reduce risks to humans on long - duration exploration missions, including NASA's Journey to Mars.

The current focus of Dr. Trakhtenberg's research is on solving the fundamental problem of the failure of CNS projection neurons to regenerate injured axons and developing translational approaches for treating optic neuropathies (eg, glaucoma) and other types of CNS injuries.

In her translational research program, Dr. Duff has created several transgenic mouse models for Alzheimer's disease (AD) to explore disease mechanisms and test therapeutic approaches.

The University of Chicago Medicine Inflammatory Bowel Disease Center is made up of a team of experts in clinical care and research, basic science and translational approaches — all working together to further knowledge of IBD causes and treatments.

Group research aims to study the relations between nutraceuticals, physical activity, intracellular mechanisms, gene expression and microbiota using a translational approach to characterize the impact in the whole body of metabolic interactions studied in individual organs and tissues (in vitro / ex vivo: skeletal muscle, heart, bone, liver and kidney).

It has invested more than $ 450 million in research to date, almost 90 percent for translational research; funded testing of more than 100 therapeutic targets for Parkinson's disease (PD); and has undertaken novel industry partnerships to support early - stage promising therapeutic approaches.

Using translational research methods, the DZL seeks to jointly develop new approaches for the prevention, diagnosis and therapy of serious lung diseases including asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, diffuse parenchymal lung disease (DPLD), endstage lung disease, lung cancer, pneumonia and acute lung injury, and pulmonary hypertension.

Working with his colleagues, Dr. Kung takes a translational approach to cancer research, integrating diverse disciplines with the ultimate goal of clinical translation.

This two - day scientific symposium will explore cutting - edge findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches.

The National Institute of Neurological Disease and Stroke recently designated spinal muscular atrophy as the model for its new approach to funding «translational research.»

As a surgeon who treats patients with head and neck cancer, Kim approaches research from a translational standpoint to understand the relationship between neoplastic transformation and the host immune response.

Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational Research in the Abramson Cancer Center, leads Penn's basic and clinical research testing these CAR - based appResearch in the Abramson Cancer Center, leads Penn's basic and clinical research testing these CAR - based appresearch testing these CAR - based approaches.

The Puppy Up Foundation's scientific objectives are: Broadening our understanding of the links between human and companion animal cancer, creating a cross institutional collaborative platform, developing new approaches to research, and funding translational cancer studies that benefit both pets and people.

The Foundation's scientific objectives are: Broadening our understanding of the links between human and companion animal cancer, creating a cross institutional collaborative platform, developing new approaches to research, and funding translational cancer studies that benefit both pets and people.